VMD

CTCP Y Dược phẩm Vimedimex · HOSE

14,500 Latest close · 30 Jun 2026 P/E 8.4x P/B 0.5x

Maintaining · Net financial result/PBT −2.51%

On a TTM 2025Q1 basis, VMD has not accelerated revenue, but profitability is improving more visibly — margins have been expanding consistently over multiple periods. Notably, most of the profit comes from non-core sources — this needs careful evaluation before concluding on growth quality.

Revenue TTM

VND 1,136bn

−59.2%

Net Margin

2.29%

+1.6pp year on year

ROE

6.3%

TTM

View Full Financial Analysis